Humana Inc HUM.N reported quarterly adjusted earnings of $6.27 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $6.96. The mean expectation of twenty four analysts for the quarter was for earnings of $5.92 per share. Wall Street expected results to range from $5.65 to $8.28 per share.
Revenue rose 10.2% to $32.39 billion from a year ago; analysts expected $31.89 billion.
Humana Inc's reported EPS for the quarter was $4.51.
The company reported quarterly net income of $545 million.
Humana Inc shares had fallen by 4.9% this quarter and lost 8.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.9% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy," 19 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is "buy."
Wall Street's median 12-month price target for Humana Inc is $284.00, about 18.1% above its last closing price of $232.62
This summary was machine generated from LSEG data July 30 at 11:00 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 5.92 | 6.27 | Beat |
Mar. 31 2025 | 10.07 | 11.58 | Beat |
Dec. 31 2024 | -2.16 | -2.16 | Met |
Sep. 30 2024 | 3.40 | 4.16 | Beat |